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Directed evolutionSqualene synthase (SQS) catalyzes the ﬁrst step of sterol/hopanoid biosynthesis in various organ-
isms. It has been long recognized that SQSs share a common ancestor with carotenoid synthases,
but it is not known how these enzymes selectively produce their own product. In this study, SQSs
from yeast, human, and bacteria were independently subjected to directed evolution for the produc-
tion of the C30 carotenoid backbone, dehydrosqualene. This was accomplished via high-throughput
screening with Pantoea ananatis phytoene desaturase, which can selectively convert dehydrosqua-
lene into yellow carotenoid pigments. Genetic analysis of the resultant mutants revealed various
mutations that could effectively convert SQS into a ‘‘dehydrosqualene synthase.’’ All of these muta-
tions are clustered around the residues that have been proposed to be important for NADPH
binding.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Sterols and hopanoids, which are both triterpenes (C30 isopre-
noids) derived from squalene (SQ), are widespread in nature.
Sterols and hopanoids have various structures and functions, such
as membrane ﬂuidity controller, hormone precursor, or serving as
the messenger for developmental signaling. In addition to its value
as a universal triterpene precursor, SQ is gaining interest as a ther-
apeutic/pharmacological chemical [1] and a biofuel candidate [2,3].
Squalene synthase (SQS) catalyzes the head-to-head condensa-
tion of two molecules of FPP to synthesize SQ (Fig. 1) [4]. SQSs have
been extensively studied over the last 50 years due to their biolog-
ical importance, their potential as targets for cholesterol lowering
drugs, and their very unique and complex mechanism of action.
SQ formation can be divided into two steps. The ﬁrst step is the
head-to-head condensation of two farnesyl diphosphate (FPP) mol-
ecules, yielding the intermediate presqualene pyrophosphate
(PSPP). This intermediate subsequently undergoes a multi-step
and reductive rearrangement into SQ. Very recently, a series of
efforts [5,6] to elucidate the structure of SQS at various reaction
stages provided a comprehensive and animated picture on how
the entire process of SQ formation proceeds.SQSs are known to be evolutionarily related to carotenoid syn-
thases. In particular, Staphylococcus aureus dehydrosqualene (DSQ)
synthase (CrtM), the ﬁrst committed enzyme in staphyloxanthin (a
C30 carotenoid pigment) synthesis [7,8], has recently been exten-
sively studied structurally [5,9–11] as an important target for
Methicillin-Resistant S. aureus (MRSA) treatment [9,12,13]. The
ﬁrst step of the reaction catalyzed by CrtM is identical to the ﬁrst
step catalyzed by SQS: CrtM condenses two molecules of FPP into
a PSPP intermediate. CrtM differs from SQS in the second reaction:
CrtM proceeds without NADPH and therefore results in the produc-
tion of DSQ (Fig. 1).
It is not known how SQS and CrtM diverged during evolution.
From the standpoint of reaction chemistry, it is expected to be
much easier to generate CrtM from SQS than vice versa: if one
can successfully impede hydride migration from NADPH to PSPP,
the second reaction is completed in a non-reductive way, leading
to DSQ formation. Indeed, it has long been known that SQS pro-
duces DSQ in the absence of NADPH [14–18]. Conversely, it has
also been suggested that NADPH acts as the trigger factor for the
ﬁrst reaction [19]. To convert SQSs into DSQ synthases with mean-
ingful cellular activity, one must disrupt hydride migration from
NADPH to the reaction precursor PSPP without severely blocking
NADPH binding.
Here, we conducted the directed evolution of SQSs from human,
yeast, and bacteria in an attempt to mimic the activity of DSQ
synthases. We successfully isolated various SQS mutants with
signiﬁcant DSQ synthase activity, and this clearly shows that it is
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Fig. 1. Reaction mechanism of squalene (SQ) and dehydrosqualene (DSQ) formation
and their conversion into carotenoid pigments. SQS mediates the condensation of
two FPPs to form PSPP, and the subsequent rearrangement and reduction of PSPP
using NADPH, to produce SQ. CrtM catalyzes the same ﬁrst reaction, but the second
rearrangement step produces DSQ instead of SQ. CrtN catalyzes the desaturation of
DSQ, also using SQ as a substrate [20] to produce diaponeurosporene and/or
diapolycopene, C30 carotenoid pigments. CrtI, conversely, uses DSQ but not SQ.
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We identiﬁed 10 DSQ-forming mutations that alone confer
DSQ-forming activities to SQSs, all of which were found near the
proposed NADPH binding domains for all three of the SQSs tested.
In general, the DSQ-forming capacity comes with the severe cost of
the original SQ-forming activity. Our results also provides unique
experimental support for the latest reaction model of SQSs [6],
where multiple regions dynamically interact with NADPH, the
key molecule which controls both the product speciﬁcity and the
reaction rate of SQSs.
2. Materials and methods
2.1. Bacterial strains
Escherichia coli XL10-Gold KanR (Stratagene, La Jolla, CA, USA)
was used for DNA cloning, while XL1-Blue (Stratagene) was used
for carotenoid or SQ production analysis.
2.2. Plasmids
pAC-hsqs and pUCara-crtI were derived from Ref. [20]. Here, the
hsqs gene was derived from pHSS16 from Thompson et al. [28],
where 30 N-terminal residues and 47 C-terminal residues were
truncated. There are 3 amino acid differences in the N-terminus
of hSQS (Q33R, D34N, and S38N) because rat SQS primers were
used initially to clone this gene [28]; however, these differences
were not reported to affect the enzyme’s behavior. E. coli codon-
optimized Thermosynechococcus elongatus BP-1 SQS (tsqs) was pur-
chased from DNA 2.0 Inc. (Menlo Park, CA). A ribosome binding
sequence and a spacer (50-AGGAGGATTACAAA-30) were added
before the open reading frame of tsqs, ﬂanked by XbaI/XhoI. This
construct was inserted into the XbaI/XhoI site of pAC-hsqs, thereby
replacing the hsqs gene to yield pAC-tsqs. Yeast SQS gene (ysqs) wasPCR-ampliﬁed from active dry yeast (Nisshin Super Kameria Dry
Yeast, Nisshin Seifun Group Inc.). PCR primers were designed so
that the C-terminal 24 amino acids of ySQS were removed. The
resultant ysqs, compared with the Saccharomyces cerevisiae SQS
gene (ERG9) sequence (NCBI Refseq NC_001140), contained three
synonymous mutations (G1125A, T1128C, T1176C) and one non-
synonymous mutation (G856A, which corresponds to Gly286Ser).
pAC-ysqs was constructed by the replacement of hsqs in pAC-hsqs
with the ysqs obtained as described above.
For the construction of single-mutation SQS variants, using
pAC-hsqs, tsqs or ysqs as a template, the whole plasmid sequences
were ampliﬁed by using the primer containing the desired muta-
tion and BsaI restriction site (primer sequence shown in
Table S4). The PCR products were digested/ligated using Golden-
Gate cloning method [29]. The ORF sequences were conﬁrmed
for each variant plasmids.
2.3. Carotenoid pigment analysis
Carotenoid pigment production in E. coli cells was measured
using a previously described method [20]. Brieﬂy, we cultured cells
in 500 lL LB-Lennox medium in a 96-deep-well plate for 16 h at
37 C. Aliquots (40 lL) of these pre-cultures were transferred to
2 mL Terriﬁc Broth (TB) medium in 48-deep-well plates and sha-
ken at 30 C, 1000 rpm. Then, 0.2% (w/v) arabinose was added after
8 h, and cultures were shaken for an additional 40 h. Cells were
harvested and washed with saline, and carotenoids were extracted
from the cell pellet by adding 1 mL acetone, which was
immediately followed by vortexing. The acetone layer was col-
lected after centrifugation (15,000 rpm for 10 min), and carote-
noids were analyzed by absorption spectroscopy (350–650 nm at
5-nm intervals). The pigmentation level of each culture was esti-
mated from the lambda max (470 nm) of the resulting extract,
using the molar absorption coefﬁcients of diaponeurosporene
(147,000 M1cm1).
2.4. Directed evolution of hSQS, tSQS, and ySQS
The hsqs gene was subjected to error-prone PCR by adding 10 or
50 lM Mn2+ to the PCR reaction (using 5U Taq polymerase from
New England Biolabs, Ispwich, MA, and a PCR program of 94 C
for 5 min followed by 25 cycles of [94 C for 30 s, 52 C for 30 s,
72 C for 1.5 min], and a ﬁnal extension of 72 C for 7 min), using
the following primers: Fwd: 50-AGCTGGGGATCCAGGTTTCCC-
GACTGGAAAGCG-30, and Rev: 50-ACCATAGGATCCGTGAAATACCG-
CACAGATGCG-30. Similarly, tsqs and ysqs were PCR-ampliﬁed
under the same mutagenic conditions using the same primers.
The resultant PCR products were digested using XbaI/XhoI and
cloned into the XbaI/XhoI site of pAC-hsqs. Ligation products were
transformed into XL10-Gold KanR (for hSQS and tSQS) or Electro-
Max DH10B (for ySQS). For the hSQS and ySQS libraries, the trans-
formants were inoculated into 40–50 mL LB (supplemented with
50 lg/mL carbenicillin) and cultured for 12 h, and plasmid libraries
were obtained by miniprepping the respective cultures. A portion
(approximately 1/1000) of each transformant was plated onto an
agar plate to determine the library sizes (approximately 105). For
the tSQS library, the transformants were plated onto several LB-
agar plates to form colonies, and the plasmid library was obtained
by miniprepping the collected colonies. The size of the tSQS library
was approximately 7500.
Plasmid libraries were transformed into XL1-Blue harboring
pUCara-crtI, plated onto an LB-agar plate topped with a nitrocellu-
lose membrane, and incubated for 16 h at 37 C to form colonies.
The colonies on the membrane was transferred to an LB-agar plate
containing 0.2% (w/v) arabinose and incubated for 24–48 h at room
temperature (approximately 25 C). The colonies were screened;
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Fig. 2. Pigmentation of E. coli cells expressing SQSs, together with desaturase CrtN
or CrtI. E. coli cells were transformed with pACYC-based plasmids expressing
human, yeast, or Thermosynechococcus SQS (hSQS, ySQS or tSQS, respectively) or
carotenoid synthase CrtM, as well as pUC-based plasmid expressing desaturases
(CrtN or CrtI). The transformant cells were cultured in 48-deep well plates,
harvested by centrifugation (pellet shown in the lower panel), and acetone-
extracted for carotenoid pigment analysis. The bar heights show the average of 3
samples, and error bars indicate the standard deviation.
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plasmids were collected from these colonies.
2.5. Carotenoid/SQ composition analysis by HPLC
Plasmids were transformed into E. coli XL1-Blue, and the trans-
formants were plated onto LB-Lennox agar plates containing
30 lg/mL chloramphenicol (Cm) to form colonies. These colonies
were picked and inoculated into 10 mL LB-Lennox (Cm) medium
in 50-mL Falcon tubes and cultured at 37 C, 200 rpm for 16 h.
An aliquot (400 lL) of these pre-cultures was transferred to
40 mL TB (Cm) in a 200-mL shake ﬂask and cultured at 30 C,
200 rpm. After 48 h, cells were harvested at 3300g for 15 min
at 4 C, washed with 10 mL saline, and then re-pelleted by centri-
fugation. After brief vortexing, carotenoids were extracted by the
addition of 10 mL acetone, followed by additional vortexing for
5 min. One milliliter hexane and 35 mL 1% NaCl (aq) were added
to the acetone extract, which was brieﬂy vortexed and centrifuged
to collect the hexane phase. The hexane was then evaporated
under a stream of N2. The extracts were then dissolved in 100 lL
(4:6) methanol/THF. A 25-lL aliquot of the ﬁnal extract was ana-
lyzed using a Shimadzu Prominence HPLC system (Shimadzu,
Kyoto) equipped with a photodiode array detector and a Spheri-
sorb ODS 2 column (250  4.6 mm, 5 lm particles; Waters, Mil-
ford, MA). The mobile phase was acetonitrile/tetrahydrofuran/
methanol (58:4:38 v/v, 2 mL min1), unless otherwise indicated.
SQ was identiﬁed and quantiﬁed by peak area using a calibra-
tion curve generated from known amounts of SQ (Nakalai Tesque,
Kyoto). DSQ was identiﬁed by the comparison of chromatogram
and absorbance spectra with DSQ prepared by in vitro reaction
using puriﬁed his-tagged CrtM and FPP (purchased from Sigma–
Aldrich), based on the protocol reported by Ref. [30]. DSQ was
quantiﬁed by peak area using a calibration curve generated from
known amounts of b-carotene (quantiﬁed by absorbance) and then
multiplying the result by the molar extinction coefﬁcient (e) of b-
carotene (138,900 M1cm1 at 450 nm [31]) and dividing by the
e value for DSQ (49,800 M1cm1 at 287 nm). The production
weights of DSQ were then normalized to the dry cell weight
(DCW) of each culture. The DCW was calculated using an OD600-
DCW calibration curve.
3. Results
3.1. Screening strategy for DSQ (but not SQ) synthesis
To establish a high-throughput screen for DSQ synthesis, we
originally planned to co-express DSQ desaturase (CrtN) from S. aur-
eus. This enzyme was identiﬁed in the staphyloxanthin biosyn-
thetic pathway [7,8] and desaturates DSQ to produce
diaponeurosporene or diapolycopene, yellow-colored C30 caroten-
oid pigments (Fig. 1). Recently, we discovered that the co-expres-
sion of human SQS (hSQS) and CrtN in E. coli resulted in the
accumulation of C30 carotenoid pigments [20]. Our results indi-
cated that CrtN is able to desaturate both SQ and its natural sub-
strate DSQ into C30 carotenoid pigments (Fig. 1) [20]. In contrast,
C30 carotenoid pigments were produced when phytoene desatur-
ase (CrtI) from the C40 carotenoid pathway in Pantoea ananatis
[21] was co-expressed with CrtM in E. coli, but not when co-
expressed with hSQS [20]. Thus, CrtI can clearly distinguish DSQ
from SQ. Given these results, we determined that pigmentation
(coloration of colonies) in CrtI-expressing cells could be used to
isolate SQS variants with DSQ synthase activity.
To test the applicability of this screening principle, we co-
expressed CrtN and CrtI with SQSs from three different organisms:
human SQS (hSQS) [4], S. cerevisiae SQS (ySQS) [22], and T. elonga-
tus BP-1 SQS (tSQS) [23]. The membrane-binding N- or C-terminalsequences of these genes were truncated (see the Materials and
Methods section), and the genes were cloned under a lac promoter
on a pACYC-based plasmid. We transformed the hsqs, ysqs, or tsqs-
encoding plasmids into E. coli harboring either CrtI or CrtN (on
pUC18-based plasmids under arabinose promoter regulation).
The transformant cells were cultured and collected to check pig-
mentation (Fig. 2). As expected, the expression of these three SQSs
together with CrtN resulted in the coloration of the cell (pellets),
reﬂecting the accumulation of C30 carotenoid pigments. In contrast,
the expression of these SQSs together with CrtI did not change the
cell color, and no carotenoid pigments were detected from those
transformant cells (Fig. 2).
3.2. Laboratory evolution of SQSs for DSQ biosynthesis
We inserted random mutations into each gene encoding hSQS,
ySQS, and tSQS, and cloned these mutated genes into pACYC-based
vectors to create the plasmid libraries pAC-[hsqs], pAC-[ysqs], and
pAC-[tsqs] (Fig. 3). These plasmid libraries were then introduced
into E. coli cells harboring pUCara-crtI. Transformants were plated
onto nitrocellulose membranes on LB-agar plates to form colonies.
The membranes were then placed on a fresh LB-agar plates con-
taining arabinose to induce crtI. After 48 h of incubation, most of
the colonies stayed pale, but we found signiﬁcant numbers of yel-
low colonies (Fig. 3). Of the 7500, 14,500, and 3500 colonies that
we screened from the hSQS, ySQS, or tSQS libraries, we isolated
6, 2, and 11 yellow colonies, respectively. Among the 19 picked,
we found some variants showed exact the same mutation (Y1/
Y2, T2/T4/T9, T10/T11, see Tables S2 and S3). We removed the 4
duplicates (Y2, T4, T9 and T11), and ﬁnally, 15 unique variants
were isolated (6, 1 and 8 variants from hSQS, ySQS and tSQS
library, respectively).
The plasmids isolated from yellow colonies were introduced
into fresh E. coli cells harboring pUCara-crtI to evaluate the produc-
tion levels of C30 carotenoid pigments (Fig. 4). Cells expressing
parental (wild-type) SQSs accumulated almost no C30 pigments.
All of the SQS variants were found to produce increased levels of
C30 pigments (up to 0.1, 0.3 and 0.7 mg/L for ySQS, hSQS
and tSQS variants, respectively, Fig. 4), indicating that the screen-
ing shown in Fig. 3 effectively isolated SQS variants with signiﬁcant
shifts in product speciﬁcity to DSQ. Indeed, expressing the isolated
plasmids of SQS variants (without CrtI) in E. coli resulted in the
increase of DSQ formation and decrease of SQ formation (Fig. S2).
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We then analyzed the mutations in the isolated SQS variants
(Fig. 5, Table S1–S3). Four evolutionary conserved regions are
shared among SQSs, named Regions I to IV [6], and these regions
are assumed to be involved in substrate/cofactor recognition and
catalysis. Regions I–III are also found in DSQ synthase, while
Region IV is unique to SQS and has been long suspected to be
responsible for NADPH binding [4,6,23,24] (see Fig. S1 for the full
sequence alignment of hSQS, ySQS, and tSQS). Most of the isolated
variants possessed more than two mutations, but all of the variants
shared one or two mutations in Regions I, III, and IV.
Among the mutations that we identiﬁed, we observed some
common mutations in Region I, III and IV (Fig. 5). The most prom-
inent mutations were found in Region I; as many as 10 of the 15
DSQ-synthesizing variants possessed mutations in this region (res-
idues 51–54 in hSQS, 50–53, in ySQS and 35–38 in tSQS, indicated
in red in Fig. 5). Obviously, mutating this region seems to be theN214D
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Fig. 6. Product analysis of single-mutation SQS variants. Indicated mutations were
inserted into (a) hSQS, (b) ySQS and (c) tSQS variants, and the product formation of
the transformed E. coli culture were analyzed using HPLC. HPLC chromatogram for
other mutants that did not showed DSQ synthase activities are shown in Fig. S4.
Dashed line shows the 5-fold absorbance at 287 nm for hSQS and ySQS variants. The
mobile phase used was acetonitrile/tetrahydrofuran/methanol (58:4:38 v/v,
2 mL min1). The peaks neighboring that of SQ (at 10.2 min and 12.5 min) were
identiﬁed as quinone, based on the characteristic maximum absorbance at 207 nm
and 275 nm.most accessible and common solution for the three tested SQSs
to acquire DSQ-forming capability. To conﬁrm whether these
mutations alone can confer the DSQ formation capacity to SQSs,
we created single-mutation variants hSQSR52G, hSQSS53G, ySQSR51I.
tSQSS35T, tSQSR36C, tSQSF38Y. The plasmid harboring these genes
were used to transform E. coli cells to analyze product formed
using HPLC (Fig. 6), or also introduced into E. coli cells harboring
pUCara-crtI to analyze the production level of C30 carotenoid pig-
ments (Fig. S3). While the wildtype SQSs produced only SQ but
no DSQ, the variants with mutations on Region I all showed
increase in DSQ formation (Fig. 6, mutant name indicated in red
characters). These residues (located in the loop connecting helix
A and B) form the ‘‘ﬂap’’ of the substrate cavity [4], termed the
AB-ﬂap (Fig. 7) [4,6]. Recently, this AB-ﬂap of hSQS was proposed
to be deeply involved both in substrate and NADPH binding [6].
Recently, Liu et al. [6] substituted the neighboring positively
charged residue R218 of hSQS (indicated by circles in Fig. 7a) withhSQS
tSQS
ySQS
45
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Fig. 7. Sequence alignment and structural mapping of the mutations found in this
study. (a) Amino acid sequence alignment of hSQS, ySQS, and tSQS surrounding the
DSQ-forming mutations in Regions I, III, or IV. The residues where DSQ-forming
mutations were identiﬁed in this study are highlighted in colors (red, blue or green).
Note that the alignment shown is only a portion of each region (for the full-length
sequence alignment, see Fig. S1). Three positively charged residues, indicated in
yellow circles, were recently suggested to be involved in NADPH recognition [6]. (b)
Human SQS structure [6] (PDB ID: 3VJ8). The DSQ-forming mutations found in this
study are indicated in colors according to subpanel a. JK-loop is indicated in black.
3380 M. Furubayashi et al. / FEBS Letters 588 (2014) 3375–3381other amino acids and observed a marked decrease in SQ formation
and NADPH afﬁnity. It however remains unknown whether this
decrease in NADPH afﬁnity lead to the loss of total activity or to
the ‘re-direction’ of reaction cascade. Three variants hSQSmut3,
tSQSmut5, and tSQSmut7 possessed mutations in Region III (high-
lighted in blue, Fig. 5). We created single mutant variants of SQS
in this region: N215D found in hSQSmut3, V213E found in tSQSmut7,
and N214D found in tSQSmut5. All of these mutants showed clearly
increased DSQ-forming activity, while the extent of the loss of ori-
ginal SQ-forming activity varied (Figs. 6 and S3, mutant name indi-
cated in blue characters).
Historically, Region IV is the ﬁrst domain that has been suggested
to be involved in NADPH binding [4,23,24]. While this domain is
conserved among SQSs, it is not found in carotenoid synthase CrtM.
Liu et al. [6] substituted the positively charged residue K315 and
R317 in JK-loop (Fig. 7a), and observed a decrease in SQ formation.
Helix aK, which is located next to the JK-loop, is in the same Region
IV, and has been proposed to regulate both the binding of substrates
andNADPH togetherwith AB-ﬂap and JK-loop [6,19].We found sev-
eral tSQS variants possessed mutations in JK-loop (S321G) or helix
aK (V325D) (Fig. 5). Here again we constructed the single mutation
variants of tSQS and tested for their in vivo functions when
expressed alone in E. coli. Among the two, tSQSV325D showed signif-
icant increase in DSQ formation, while S321G did not show any DSQ
formation (Figs. 6 and S4). In addition, the cells expressing tSQSV325D
accumulated the largest amount of DSQ while showed drastic
decrease in the original SQ-forming activity, thus achieving the
switching into selective DSQ synthase (Figs. 6c and S3). V325 is
located on helix aK of SQS structure, facing inside the substrate cav-
ity (Fig. 7b). It is tempting to assume that the negative-charged
aspartate at 325th residue slightly changes the binding conﬁgura-
tion of NADPH, thereby selectively preventing the hydride migra-
tion without losing the total activity. It is also intriguing that the
mutations in JK-loopwere not found in this study from any SQS syn-
thases despite the large screening size. It is possible that these
mutations effectively lowered the NADPH binding afﬁnity but also
decreased the total enzyme activity.
4. Discussion
SQS is located at the entry point to the sterol and hopanoid
pathways, and it synthesizes the common precursor SQ with
remarkable speciﬁcity. All three SQSs tested in this study have
Km values ranging 0.2–0.5 mM for NADPH [23,25,26], which is
comparable to the reported NADPH concentration values in E. coli
(0.56 mM) [27]. Given these data, a non-negligible fraction of SQSs
should be NADPH-free in E. coli cells. Nevertheless, in E. coli cul-
tures expressing hSQS, the amount of DSQ produced was below
1% of the total products [20]. This result indicates that SQSs have
a sophisticated mechanism to prevent the accidental formation of
DSQ. In this study, we performed a directed evolution of SQSs for
DSQ production in E. coli. This way we could search for the SQS
variants that can produce DSQ even in the presence of NADPH.
We obtained several variants that signiﬁcantly increase the DSQ
synthase activity.
There is no apparent NADPH binding motif (such as Rossman
Fold) in SQSs, and the mechanism of NADPH binding to SQSs has
been unsolved for years. The involvement of Region IV in NADPH
binding has been long suspected due to the conservation of this
region among SQSs and the lack of them in DSQ/phytoene syn-
thases [4,23,24]. Recently, Liu et al. [6] reported several intermedi-
ate structures of SQSs bound to several substrates and proposed a
comprehensive and persuasive reaction model for SQS based on
those results. Their model suggested the importance of the posi-
tively charged residues in Region I and Region III (shown in yellowin Fig. 7b) in addition to Region IV. In this work, we isolated 18
DSQ-producing mutants from three different SQSs. All of the iden-
tiﬁed mutants contained mutation(s) in these putative NADPH-
binding domains in Region I, III and IV. Considering that blocking
hydride migration from NADPH should be effective, in theory, to
re-direct the ﬁnal product from SQ to DSQ, our results indicate
the accuracy and universality of the current view on how NADPH
interacts with SQSs [6].
Mutations in the three NADPH-capturing regions did not appear
to be equivalent in generating DSQ-forming capabilities: our
screening resulted in enriched mutations in the AB-ﬂap (in Region
I) for all three SQSs, and these mutations were found in almost all
of the variants of hSQS and ySQS that were isolated. It is likely that
mutations in Regions III and IV abolish NADPH binding, but many
of these mutations are likely counter-selected against by the
screen for DSQ formation because they also eliminate the
NADPH-triggered ﬁrst half reaction to generate PSPP, the precursor
for DSQ. To ‘redirect’ the reaction cascade, mutations must some-
how effectively disrupt hydride migration while preserving the
other role of NADPH as a trigger factor/initiator of the ﬁrst half
reaction [19]. Redirection might also be possible with mutations
that enable SQSs to efﬁciently initiate the ﬁrst half reaction with-
out NADPH. This work showed that various (at least) mutations
confer signiﬁcant carotenoid synthase activity to SQS. A biochem-
ical analysis of the resultant mutants is necessary to establish a
detailed explanation on how these mutations affect the reaction
mechanism.
Finally, our work suggests a new mode to control cholesterol
biosynthesis. Here, we show that a small structural change, caused
especially by mutations near or in the AB-ﬂap, could signiﬁcantly
redirect SQS toward DSQ, which cannot act as a precursor for cho-
lesterol synthesis. By searching for chemicals that bind to this lar-
gely solvent-exposed region and exercise effects similar to the
mutations that we found, one could access a new class of choles-
terol-lowering drugs that do not inhibit SQS activity but switch
its product speciﬁcity instead.
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